Evercore ISI Group Initiates Coverage On Elevance Health with In-Line Rating, Announces Price Target of $345

Benzinga Newsdesk www.benzinga.com Positive 68.2%

Neg 0% Neu 0% Pos 68.2%

Evercore ISI Group analyst Elizabeth Anderson initiates coverage on Elevance Health (NYSE:ELV) with a In-Line rating and announces Price Target of $345.